| Issue |
BIO Web Conf.
Volume 184, 2025
The 3rd International Seminar of the Indonesian Society for Biochemistry and Molecular Biology (ISISBMB 2025)
|
|
|---|---|---|
| Article Number | 01016 | |
| Number of page(s) | 8 | |
| Section | Health Biochemistry | |
| DOI | https://doi.org/10.1051/bioconf/202518401016 | |
| Published online | 12 August 2025 | |
An Overview of Drug Prescription in Gastritis Patients at Mangusada Regional Hospital from 2019 to 2023
1 Faculty of Medicine and Health Science, Universitas Warmadewa, Denpasar 80239, Indonesia
2 Lyceum of the Philippines University–Batangas (LPU-Batangas), Batangas 4200, Philippines
* Corresponding author: putunitacahyawati@gmail.com
Gastritis is one of the most common digestive system disorders. Its prevalence in Indonesia is reported to reach 64.9%. This study aims to determine the pattern of drug prescribing among patients with gastritis in Bali. This is a descriptive observational study with a cross-sectional approach. This research was conducted at the Mangusada Regional Hospital. The total sample in the study was 132. This study examines the characteristics of patients and pharmacological therapies based on medical record data. The study found that the majority of patients were men (59.1%) and were between 46 and 65 years old (43.9%). The majority had acute gastritis (87.9%) and had no comorbid diseases. The type of therapy used in patients was polytherapy, involving two types of drugs (60.7%), with the most common combinations found in the proton pump inhibitor (PPI) and cytoprotective groups (48.5%). PPI is the highest prescribed drug (46%). This study concluded that the treatment of gastritis is dominated by the use of polytherapy, with the most common combination being a PPI and a cytoprotective agent. PPI is the highest prescribed drug. Based on these findings, it is recommended that future research focus on evaluating the clinical effectiveness and cost-effectiveness of the therapy.
Key words: acute gastritis / chronic gastritis / PPI / antacids / drug prescribing
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.